Insider Transactions in Q2 2022 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 24
2022
|
Marc Tessier Lavigne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
46,750
-1.16%
|
$1,402,500
$30.81 P/Share
|
|
Jun 23
2022
|
Marc Tessier Lavigne Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
13,250
-0.65%
|
$410,750
$31.1 P/Share
|
|
Jun 02
2022
|
Nancy Thornberry Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+41.33%
|
-
|
|
Jun 02
2022
|
Jay T Flatley Director |
BUY
Grant, award, or other acquisition
|
Indirect |
5,986
+1.75%
|
-
|
|
Jun 02
2022
|
Jennifer E. Cook Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+34.6%
|
-
|
|
Jun 02
2022
|
Vicki L Sato Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+4.04%
|
-
|
|
Jun 02
2022
|
Douglas G. Cole Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+21.13%
|
-
|
|
Jun 02
2022
|
Marc Tessier Lavigne Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+0.29%
|
-
|
|
Jun 02
2022
|
Peter S Klein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+34.6%
|
-
|
|
Jun 02
2022
|
David P Schenkein Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,986
+34.6%
|
-
|